Tetraphase Pharmaceuticals (TTPH) PT Lowered to $6 at B.Riley/FBR, 'IGNITE3 Failure Limits but Does Not Quash Eravacycline Opportunity'

February 14, 2018 4:29 AM

B.Riley/FBR lowered its price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found